Idiopathic Thrombocytopenic
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
ITP is a growing but little understood health problem that most people (including some medical professionals have never heard of. It affects individuals of all ages, sexes and ethnic origins. ITP affect tens times as many people as hemophilia.
ITP is an autoimmune disease that causes the body to mount an attack on platelets that are imperative to clotting in the blood. In addition to increased platelet destruction, some people with ITP also have impaired platelet production. Without a sufficient number of platelets, a person with ITP is subject to spontaneous bleeding or bruising. This bruising is oftentimes mistaken for child abuse.
Fortunately, substantial progress in understanding the mechanisms of ITP has been made in recent years. New treatments are now available. As research continues, however, the challenge continues to educate healthcare professionals and the public about this disorder. ITP patients and caregivers often feel they know more about the disease than their healthcare providers. As a result there has been an increasing need for ITP Centers of Excellence to study, treat and accurately record data to further understand the disease. Similar center have proven highly successful for studying, recording and treating other bleeding disorders like hemophilia and sickle sell disease. To read more about ITP in children, click here.
ITP is an autoimmune disease that causes the body to mount an attack on platelets that are imperative to clotting in the blood. In addition to increased platelet destruction, some people with ITP also have impaired platelet production. Without a sufficient number of platelets, a person with ITP is subject to spontaneous bleeding or bruising. This bruising is oftentimes mistaken for child abuse.
Fortunately, substantial progress in understanding the mechanisms of ITP has been made in recent years. New treatments are now available. As research continues, however, the challenge continues to educate healthcare professionals and the public about this disorder. ITP patients and caregivers often feel they know more about the disease than their healthcare providers. As a result there has been an increasing need for ITP Centers of Excellence to study, treat and accurately record data to further understand the disease. Similar center have proven highly successful for studying, recording and treating other bleeding disorders like hemophilia and sickle sell disease. To read more about ITP in children, click here.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
PDSA is the number one resource for patients with chronic ITP and other platelet disorders, providing education, advocacy, research and support. Whether through their website, print publications, support groups or annual and regional meetings, PDSA's goals are to provide answers about the disease with the most up-to-date information, a personal connection and a reassuring voice.
No comments:
Post a Comment